Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

HSCS

HeartSciences Inc

Dec 11 • 10:22AM ET

4.02

Dollar change -0.01
Percentage change -0.22	%

Healthcare • Medical Devices • USA • NASD

Peers: JNJ ABT BAX MDT SYK BSX TMO EW RMD ZBH

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-24.41	Insider Own	10.64%	Shs Outstand	0.91M	Perf Week	17.58%
Market Cap	3.67M	Forward P/E	-	EPS next Y	-6.07	Insider Trans	0.00%	Shs Float	0.82M	Perf Month	40.60%
Income	-7.29M	PEG	-	EPS next Q	-2.33	Inst Own	1.43%	Short Float	6.70%	Perf Quarter	44.13%
Sales	0.02M	P/S	183.60	EPS this Y	64.66%	Inst Trans	4.07%	Short Ratio	0.15	Perf Half Y	-24.13%
Book/sh	6.55	P/B	0.61	EPS next Y	32.29%	ROA	-135.14%	Short Interest	0.05M	Perf Year	-76.55%
Cash/sh	4.75	P/C	0.85	EPS next 5Y	-	ROE	-269.29%	52W Range	2.36 - 19.14	Perf YTD	-76.48%
Dividend Est.	-	P/FCF	-	EPS past 5Y	20.70%	ROI	-106.58%	52W High	-78.99%	Beta	3.12
Dividend TTM	-	Quick Ratio	3.53	Sales past 5Y	23.26%	Gross Margin	-222.33%	52W Low	70.39%	ATR (14)	0.34
Dividend Ex-Date	-	Current Ratio	4.00	EPS Y/Y TTM	63.81%	Oper. Margin	-37907.43%	RSI (14)	65.84	Volatility	16.87% 9.48%
Employees	15	Debt/Eq	0.17	Sales Y/Y TTM	853.85%	Profit Margin	-39193.77%	Recom	1.00	Target Price	13.50
Option/Short	No / Yes	LT Debt/Eq	0.15	EPS Q/Q	80.06%	Payout	-	Rel Volume	0.07	Prev Close	4.03
Sales Surprise	-	EPS Surprise	-13.02%	Sales Q/Q	-	Earnings	Sep 12	Avg Volume	366.62K	Price	4.02
SMA20	26.44%	SMA50	21.30%	SMA200	-31.76%	Trades		Volume	4,450	Change	-0.22%

Nov-13-24 09:00AM	HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement (GlobeNewswire)
Oct-14-24 04:15PM	HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit (GlobeNewswire) +5.92% -5.03%
Sep-12-24 04:15PM	HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results (GlobeNewswire) +8.96%
09:00AM	HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission (GlobeNewswire)
Jul-29-24 04:05PM	HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results (GlobeNewswire) -10.26% -6.81%
09:00AM	Loading…
Jul-26-24 09:00AM	Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista wavECG Potential to Improve Cardiovascular Pathway Efficiency (GlobeNewswire) +22.13%
Jul-25-24 08:30AM	HeartSciences Selected to Demonstrate MyoVista wavECG at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare (GlobeNewswire)
Jul-11-24 09:00AM	HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction (GlobeNewswire) -8.60%
Jun-04-24 04:15PM	HeartSciences Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire) -9.49% +7.77%
May-20-24 09:00AM	HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio (GlobeNewswire) -15.64%
May-13-24 07:23AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) -19.77%
Apr-24-24 09:00AM	HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG (GlobeNewswire) +9.10%
Apr-02-24 04:15PM	HeartSciences to Present at the LD Micro Invitational XIV Conference (GlobeNewswire) -6.09%
Mar-26-24 09:00AM	HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients (GlobeNewswire)
Mar-14-24 09:54PM	HSCS Stock Earnings: Heart Test Laboratories Beats EPS for Q3 2024 (InvestorPlace) +5.75%
04:15PM	Loading…
04:15PM	HeartSciences Reports Third Quarter Fiscal 2024 Financial Results (GlobeNewswire)
Mar-12-24 09:00AM	HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes (GlobeNewswire)
Mar-06-24 09:20AM	Why Is Heart Test Laboratories (HSCS) Stock Down 21% Today? (InvestorPlace) -27.41%
09:00AM	HeartSciences Announces Canada Patent Grant Covering MyoVista Wavelet Technology (GlobeNewswire)
Feb-26-24 09:00AM	HeartSciences Adds Key Advisor to its Scientific Advisory Board (GlobeNewswire)
Feb-12-24 09:00AM	HeartSciences Expands its Scientific Advisory Board (GlobeNewswire)
Feb-01-24 09:00AM	HeartSciences Appoints New Scientific Advisory Board Member (GlobeNewswire) -5.87%
Jan-18-24 08:00AM	HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting (GlobeNewswire) -17.05%
Jan-03-24 04:15PM	HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting (GlobeNewswire) -6.31%
Dec-18-23 11:52AM	HSCS Stock Earnings: Heart Test Laboratories Misses EPS for Q2 2024 (InvestorPlace) -8.24%
Dec-14-23 04:15PM	HeartSciences Reports Second Quarter Fiscal 2024 Financial Results (GlobeNewswire) +12.09%
Dec-05-23 08:00AM	HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway (GlobeNewswire)
Nov-20-23 08:00AM	HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms (GlobeNewswire) +11.65%
Nov-15-23 08:07AM	Why Is Heart Test Laboratories (HSCS) Stock Up 43% Today? (InvestorPlace) -16.62%
Nov-13-23 08:45AM	HeartSciences' MyoVista wavECGTM Selected for Heart Screening of Irish Garda National Police Officers (GlobeNewswire)
07:54AM	Loading…
Nov-08-23 07:54AM	Why Is Heart Test Laboratories (HSCS) Stock Up 298% Today? (InvestorPlace) +53.38%
Oct-19-23 09:00AM	HeartSciences Issues Investor Update Highlighting Recent Key Achievements and Positive Developments (GlobeNewswire)
Sep-26-23 08:00AM	HeartSciences Receives Two New Patent Allowances, Expanding its International Patent Portfolio (GlobeNewswire)
Sep-25-23 08:00AM	HeartSciences to Participate in the Maxim Group Virtual Tech Conference Series: Emerging Growth in A.I. (GlobeNewswire) -6.57%
Sep-21-23 08:00AM	HeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular Algorithms (GlobeNewswire)
Sep-14-23 04:15PM	HeartSciences Reports First Quarter Fiscal 2024 Financial Results (GlobeNewswire)
Sep-12-23 04:15PM	HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase (GlobeNewswire)
Sep-11-23 04:15PM	HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards (GlobeNewswire)
Sep-07-23 09:00AM	HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India (GlobeNewswire)
Aug-31-23 09:00AM	HeartSciences Signs Distribution Agreement with FJ Medical, Denmark (GlobeNewswire)
Aug-24-23 09:00AM	HeartSciences MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation (GlobeNewswire)
Aug-17-23 10:36AM	EXCLUSIVE: HeartSciences Announces Expansion of Artificial Intelligence Patent Portfolio (Benzinga)
09:00AM	HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio (GlobeNewswire)
Jul-27-23 09:00AM	MyoVista wavECG goes into clinical use at the Naya Imaging Center in Denmark (GlobeNewswire)
Jul-19-23 09:00AM	HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results (GlobeNewswire) -5.26%
May-17-23 08:00AM	HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine (GlobeNewswire)
May-09-23 08:15AM	HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG (GlobeNewswire)
May-08-23 08:15AM	HeartSciences to Participate at the Inaugural EF Hutton Global Conference (GlobeNewswire)
May-02-23 08:15AM	HeartSciences to Participate in The Benchmark Companys Virtual Individual Investor Healthcare Conference (GlobeNewswire)
Apr-24-23 09:00AM	Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV (ACCESSWIRE) -10.11%
Apr-17-23 08:15AM	HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023 (GlobeNewswire) +9.10%
Mar-18-23 08:39AM	Heart Test Laboratories Reports Third Quarter 2023 Earnings (Simply Wall St.)
Mar-16-23 04:15PM	HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results (GlobeNewswire) -8.18% +9.90%
Feb-07-23 11:04AM	HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 a.m. Pacific Time (GlobeNewswire)
Feb-06-23 07:30AM	HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease (GlobeNewswire) -17.65%
Feb-03-23 09:00AM	HeartSciences Announces Further Internationalization of its Patent Portfolio (GlobeNewswire) +139.44%
Jan-24-23 11:00AM	Maxim Group LLC to Host the Healthcare IT Virtual Conference on Wednesday, January 25th at 8:15 A.M. ET (GlobeNewswire)
Jan-23-23 09:00AM	Correction: HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th (GlobeNewswire)
Jan-20-23 09:00AM	HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th (GlobeNewswire)
Jan-04-23 09:00AM	HeartSciences Appoints David R. Wells to its Board of Directors, an Experienced Capital Markets and Finance Executive (GlobeNewswire)
Dec-16-22 08:30AM	HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial Results (GlobeNewswire)
Dec-01-22 09:00AM	HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms (GlobeNewswire)
Nov-28-22 09:00AM	HeartSciences to Present at the 2022 RHK Disruptive Growth Conference on December 5, 2022 (GlobeNewswire) -5.76%
Nov-21-22 09:00AM	HeartSciences to Participate at the Benchmark Discovery One-on-One Investor Conference on December 1, 2022 (GlobeNewswire)
Nov-10-22 09:00AM	HeartSciences MyoVista® Technology Used to Develop AI-ECG Algorithm to Identify Patients at High-Risk of Major Adverse Cardiovascular Events (GlobeNewswire)
Oct-25-22 09:00AM	HeartSciences Granted European Patent for Proprietary Electrode and Cable Connections for Use with its AI-Based MyoVista® ECG (GlobeNewswire) +14.02%
Oct-20-22 09:00AM	HeartSciences Named as a Top 10 MedTech Startup 2022 by MedTech Outlook Magazine (GlobeNewswire) +10.13%
Oct-19-22 09:15AM	HeartSciences Announces Major Milestone with the Issuance of CPT® Codes by the American Medical Association for ECG AI Analysis of Cardiac Dysfunction (GlobeNewswire)
08:45AM	EXCLUSIVE: Issuance Of New Reimbursement-Related Codes Validates Commercial Opportunity For HeartSciences' Flagship Product (Benzinga)
Oct-18-22 09:00AM	HeartSciences to Present at the LD Micro Main Event XV on October 26th (Newsfile)
Oct-06-22 09:00AM	HeartSciences to Present at MicroCap Rodeo's Windy City Roundup Conference on October 12th (ACCESSWIRE)
Sep-20-22 08:30AM	HeartSciences Granted U.S Patent for ECG Assessment of Heart Diastolic Function Using Artificial Intelligence (GlobeNewswire)
Sep-13-22 08:00AM	HeartSciences Provides Business Update and Reports First Quarter Fiscal 2023 Financial Results (GlobeNewswire)
Sep-12-22 08:30AM	HeartSciences to Participate and Showcase the MyoVista at the Inauguration Ceremony of the Center for Innovation at Rutgers Robert Wood Johnson University Hospital (GlobeNewswire)
Sep-08-22 08:30AM	HeartSciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-01-22 08:30AM	HeartSciences Provides Corporate Update and Reports Fiscal 2022 Financial Results (GlobeNewswire) +5.04%
Jul-13-22 02:03PM	HeartSciences CEO to Participate in the Benzinga All Access Event on July 15th (GlobeNewswire)
Jun-15-22 09:50AM	Heart Test Laboratories, Inc. Announces Pricing of $6.375 Million Initial Public Offering and Nasdaq Listing (GlobeNewswire)

HeartSciences, Inc. is a medical technology company, which focuses on applying innovative AI-based technology to an electrocardiogram (ECG) to expand and improve an ECG's clinical usefulness. Its objective is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It offers MyoVista, a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. The company was founded in 2008 and is headquartered in Southlake, TX.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HSCS

HeartSciences Inc

Upgrade your FINVIZ experience